Index trend and stocks in action May 14, 2019
Index trend and stocks in action May 14, 2019

Index trend and stocks in action May 14, 2019

DSIJ Intelligence Article rating: 3.7

The zone of 11,035-11,070 would now act as a strong support level as it is the confluence of the 61.8 per cent retracement of the entire upmove from the low of February to the April high and the rising 200 DMA. With the RSI almost near the oversold region of 30 and after a continued descend in the last nine trading sessions, Nifty has created scope for a technical pullbacks, which are likely to be resisted around the levels of 11,220 followed by 11,300. Stocks in news: Lux Industries, Engineers India, Tata Power, Avadh Sugar & Energy, Delta Corp, Shankara Building Products, Bajaj Finance, D-Link.

Markets may see red as US-China trade war escalates
Markets may see red as US-China trade war escalates

Markets may see red as US-China trade war escalates

DSIJ Intelligence Article rating: 5.0

With China retaliating against the US with punitive tariffs, the global markets felt the pain and are bleeding red. The SGX in early trading is showing weakness of 0.90 per cent and this clearly indicates that a gap-down opening is in store for the Indian markets. Now, for the Nifty, the final ray of hope is 11,035 level as it is the 200-DMA.

Market continues its losing streak, Sensex tanks 372 points
Market continues its losing streak, Sensex tanks 372 points

Market continues its losing streak, Sensex tanks 372 points

Nidhi Jani Article rating: 5.0

Meanwhile, foreign investors have taken out the net amount of Rs 3,207 crore from the Country's capital market in the first week of May amid US President's decision to impose tariff on USD 200 billion products imported from China. In addition to this, uncertainty over the election result also weighed on the market sentiments.

Caplin Point gets approval for sterile injectables from Colombia
Caplin Point gets approval for sterile injectables from Colombia

Caplin Point gets approval for sterile injectables from Colombia

Nidhi Jani Article rating: 5.0

The company is hoping that this approval would help to further expand its footprints in Latin America. The company’s Unit 1 is currently catering to emerging markets of Latin America and Africa with a variety of dosage forms such as tablets, capsules, softgel capsules, suppositories, liquid orals and topicals.

Should NRIs buy life insurance in India?
Should NRIs buy life insurance in India?

Should NRIs buy life insurance in India?

DSIJ Intelligence Article rating: 5.0

FEMA (Foreign Exchange Management Act) allows NRIs to buy any type of insurance in India. So, should you as an NRI buy one? Let’s find out.

Pennar group gets orders amounting to Rs 311cr
Pennar group gets orders amounting to Rs 311cr

Pennar group gets orders amounting to Rs 311cr

Nidhi Jani Article rating: 5.0

On Monday, Pennar group informed the bourses that it has received orders worth Rs. 311 crore for the month of April across its various business verticals.


Cadila gets USFDA approval for Chlorthalidone tablets
Cadila gets USFDA approval for Chlorthalidone tablets

Cadila gets USFDA approval for Chlorthalidone tablets

Nidhi Jani Article rating: 5.0

Chlorthalidone tablets are used to treat hypertension. These are also used to reduce extra salt and water in the body caused by conditions such as heart failure, liver disease, and kidney disease.

RSS
First32683269327032713273327532763277Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR